BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22122513)

  • 1. Economic considerations in frequent home hemodialysis.
    McFarlane P; Komenda P
    Semin Dial; 2011; 24(6):678-83. PubMed ID: 22122513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost savings of home nocturnal versus conventional in-center hemodialysis.
    McFarlane PA; Pierratos A; Redelmeier DA
    Kidney Int; 2002 Dec; 62(6):2216-22. PubMed ID: 12427148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of home nocturnal hemodialysis on end-stage renal disease therapies: a decision analysis.
    McFarlane PA; Bayoumi AM; Pierratos A; Redelmeier DA
    Kidney Int; 2006 Mar; 69(5):798-805. PubMed ID: 16407887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing hemodialysis costs: conventional and quotidian home hemodialysis in Canada.
    McFarlane PA
    Semin Dial; 2004; 17(2):118-24. PubMed ID: 15043613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The quality of life and cost utility of home nocturnal and conventional in-center hemodialysis.
    McFarlane PA; Bayoumi AM; Pierratos A; Redelmeier DA
    Kidney Int; 2003 Sep; 64(3):1004-11. PubMed ID: 12911550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The economics of home nocturnal hemodialysis: how should we cost the benefits?
    Komenda P; Levin A; Manns B
    Clin Nephrol; 2007 Sep; 68(3):151-8. PubMed ID: 17915617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nocturnal haemodialysis: an Australian cost comparison with conventional satellite haemodialysis.
    Agar JW; Knight RJ; Simmonds RE; Boddington JM; Waldron CM; Somerville CA
    Nephrology (Carlton); 2005 Dec; 10(6):557-70. PubMed ID: 16354238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating preference scores in conventional and home nocturnal hemodialysis patients.
    McFarlane PA; Pierratos A; Bayoumi AM; Redelmeier DA
    Clin J Am Soc Nephrol; 2007 May; 2(3):477-83. PubMed ID: 17699454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Home hemodialysis à la carte: a tailormade program (1998-2003).
    Piccoli GB; Bermond F; Mezza E; Soragna G; Burdese M; Jeantet A; Segoloni GP; Piccoli G
    J Nephrol; 2004; 17(1):76-86. PubMed ID: 15151262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost of starting and maintaining a large home hemodialysis program.
    Komenda P; Copland M; Makwana J; Djurdjev O; Sood MM; Levin A
    Kidney Int; 2010 Jun; 77(11):1039-45. PubMed ID: 20375983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing VA and private sector healthcare costs for end-stage renal disease.
    Hynes DM; Stroupe KT; Fischer MJ; Reda DJ; Manning W; Browning MM; Huo Z; Saban K; Kaufman JS;
    Med Care; 2012 Feb; 50(2):161-70. PubMed ID: 21945972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An operating cost comparison between conventional and home quotidian hemodialysis.
    Kroeker A; Clark WF; Heidenheim AP; Kuenzig L; Leitch R; Meyette M; Muirhead N; Ryan H; Welch R; White S; Lindsay RM
    Am J Kidney Dis; 2003 Jul; 42(1 Suppl):49-55. PubMed ID: 12830444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-Effectiveness of High Dose Hemodialysis in Comparison to Conventional In-Center Hemodialysis in the Netherlands.
    Beby AT; Cornelis T; Zinck R; Liu FX
    Adv Ther; 2016 Nov; 33(11):2032-2048. PubMed ID: 27664108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Home hemodialysis and mortality risk in Australian and New Zealand populations.
    Marshall MR; Hawley CM; Kerr PG; Polkinghorne KR; Marshall RJ; Agar JW; McDonald SP
    Am J Kidney Dis; 2011 Nov; 58(5):782-93. PubMed ID: 21816526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost analysis of dialysis treatments for end-stage renal disease (ESRD).
    Goeree R; Manalich J; Grootendorst P; Beecroft ML; Churchill DN
    Clin Invest Med; 1995 Dec; 18(6):455-64. PubMed ID: 8714789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent hemodialysis versus continuous renal replacement therapy for acute renal failure in the intensive care unit: an observational outcomes analysis.
    Rauf AA; Long KH; Gajic O; Anderson SS; Swaminathan L; Albright RC
    J Intensive Care Med; 2008; 23(3):195-203. PubMed ID: 18474503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short daily and nocturnal hemodialysis: new therapies for a new century?
    Rocco MV
    Saudi J Kidney Dis Transpl; 2009 Jan; 20(1):1-11. PubMed ID: 19112213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione and riboflavin status in supplemented patients undergoing home nocturnal hemodialysis versus standard hemodialysis.
    Kannampuzha J; Donnelly SM; McFarlane PA; Chan CT; House JD; Pencharz PB; Darling PB
    J Ren Nutr; 2010 May; 20(3):199-208. PubMed ID: 19913440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost-effectiveness of contemporary home haemodialysis modalities compared with facility haemodialysis: a systematic review of full economic evaluations.
    Walker R; Marshall MR; Morton RL; McFarlane P; Howard K
    Nephrology (Carlton); 2014 Aug; 19(8):459-70. PubMed ID: 24750559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost-effectiveness of increasing kidney transplantation and home-based dialysis.
    Howard K; Salkeld G; White S; McDonald S; Chadban S; Craig JC; Cass A
    Nephrology (Carlton); 2009 Feb; 14(1):123-32. PubMed ID: 19207859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.